Bile acid therapy in primary biliary cirrhosis (PBC). Changes of DCA/LCA ratio in fecal bile acids and consequences
✍ Scribed by Güldütuna, S.; Nickel, A.; Leuschner, M.; Leuschner, U.
- Book ID
- 123072358
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- English
- Weight
- 70 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Bile acid composition in fasting duodenal bile was assessed at entry and at 2 years in patients with primary biliary cirrhosis (PBC) enrolled in a randomized, doubleblind, placebo-controlled trial of ursodeoxycholic acid (UDCA) (10-12 mg/kg/d) taken as a single bedtime dose. Specimens were analyzed
Ursodeoxycholic acid treatment of patients with primary biliary cirrhosis may lead to relief of pruritus and improvement of biochemical liver tests. The changes in serum and urinary bile acids induced by ursodeoxycholic acid treatment were studied. After 29 patients with primary biliary cirrhosis we